Towards Newer Molecular Targets for Chronic Diabetic Complications
Journal:
Current Vascular Pharmacology
Volume:
4
Page:
45-57
Author(s):
Zia A. Khan, Hana Farhangkhoee and Subrata Chakrabarti
Cerebrovascular Damage as a Cause for Alzheimers Disease
Journal:
Current Neurovascular Research
Volume:
2
Page:
341-347
Author(s):
C. Humpel and J. Marksteiner
Localisation of Endothelin-1 and its Receptors in Vascular Tissue as Seen at the Electron Microscopic Level
Journal:
Current Vascular Pharmacology
Volume:
3
Page:
381-392
Author(s):
Andrzej Loesch
Transcranial Doppler Ultrasonography: Current Status
Journal:
Current Medical Imaging
Volume:
1
Page:
177-192
Author(s):
Alexander Y. Razumovsky
The Spleen Tyrosine Kinase (Syk) in Human Disease, Implications for Design of Tyrosine Kinase Inhibitor Based Therapy
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
1739-1744
Author(s):
Christopher S. Navara
Studies on the Transdermal Delivery of Nimodipine from a Menthol-based TTS in Human Volunteers
Journal:
Current Drug Delivery
Volume:
1
Page:
93-102
Author(s):
Y. S.R. Krishnaiah and P. Bhaskar
The Possible Therapeutic Actions of Peroxisome Proliferator-Activated Receptor α(PPARα) Agonists,PPARγ Agonists,3-Hydroxy-3- Methylglutaryl Coenzyme A (HMG-CoA)Reductase Inhibitors,Angiotensin Converting Enzyme (ACE)Inhibitors and Calcium (Ca)-Antagonists on Vascular Endothelial Cells
Journal:
Current Drug Targets - Cardiovascular & Hematological Disorders
Volume:
4
Page:
35-52
Author(s):
Ikuo Inoue and Shigehiro Katayama
“Its The Chemistry, Stupid !”, or: The Impact of Early Discovery Patent Applications on the Drug Development Process
Journal:
Current Topics in Medicinal Chemistry
Volume:
4
Page:
601-608
Author(s):
Frank Landolt
Cerebrovascular Amyloidosis and Dementia
Journal:
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume:
3
Page:
317-327
Author(s):
Raj N. Kalaria, Alan Thomas, Arthur Oakley, Paul Ince, Akira Tamaoka, Hiroshi Mori, Rose Anne Kenny and Clive Ballard